Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2005
12/15/2005CA2566518A1 Compositions and methods using same for treating neurodegenerative disorders
12/15/2005CA2563445A1 Compositions and methods for modulating vascular development
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1604661A1 Remedy for corneal ulcer
12/14/2005EP1603607A2 Self-emulsifying compositions, methods of use and preparation
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1370144A4 Noninvasive measurements of chemical substances
12/14/2005EP1247526B1 Perfusion liquid preparations for ophthalmic operations
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231226C Compound formulation for treating myopia, hypermetropia, strabismus and amblyopia
12/14/2005CN1231218C Use of medicinal composition in preparing medicine for treating middle ear infections
12/14/2005CN1231214C 5HT2 agonists for controlling IOP and treating glaucoma
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974823 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974581 Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
12/13/2005CA2314571C Methods and compositions for treating diseases and conditions of the eye
12/13/2005CA2240271C Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005115475A1 Thickener for ophthalmic use
12/08/2005WO2005115411A1 Agent for visualizing transparent tissue
12/08/2005WO2005115408A1 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272036 Ketones
12/08/2005US20050271748 Compositions for treating hyperemia
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005CA2567411A1 Transparent tissue-visualizing preparation
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602373A1 Ocular hypotensive agent
12/07/2005EP1602370A2 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
12/07/2005EP1601767A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF EIF-5A1
12/07/2005EP1601362A2 Use of diazoxide in the treatment of ischemia retinae
12/07/2005EP1601351A1 Use of ep2 selective receptor agonists in medical treatment
12/07/2005EP1463408A4 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1368309B1 Thiol-modified hyaluronan
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294717B1 A thiazine oxazolidinone
12/07/2005EP1267806B1 Use of cosmetic and pharmaceutical compositions comprising 2-decarboxy-2-phosphinico derivatives of prostaglandins
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1124548B1 Compositions for the treatment and prevention of cardiovascular diseases
12/07/2005EP1049466B1 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
12/07/2005CN1704121A Anti-angiogenic compositions and methods of use
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230174C Selective iGLuR5 receptor antagonists for the treatment of migraine
12/07/2005CN1230173C Preventives and remedies for complications of diabetes
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2180846C Method of treating disorders of the eye
12/03/2005CA2529613A1 Agent for repairing corneal sensitivity containing amide compound
12/01/2005WO2005113586A2 Disease-associated proteins
12/01/2005WO2005113490A1 Sulfone-containing prodrugs
12/01/2005WO2005113002A1 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
12/01/2005WO2005009460A3 Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
12/01/2005US20050267486 Methods and compositions usable in cataract surgery
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267088 Compositions for treating hyperemia
12/01/2005US20050267032 Sulfone-containing prodrugs
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266108 Methods of purifying cannabinoids from plant material
12/01/2005US20050266089 Contact lens and eye drop rewetter compositions and methods
12/01/2005US20050265937 Systems and methods for changing eye color appearance
12/01/2005CA2838526A1 Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer
11/2005
11/30/2005EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1599591A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 531